First Mercantile Trust’s PTC Therapeutics PTCT Stock Holding History

First Mercantile Trust’s Portfolio PTCT Stock Details PTCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$88K	Buy	2,371 +366	+18%	+$15K	0.01%	693
2021 Q2	$85K	Sell	2,005 -215	-10%	-$9.21K	0.01%	727
2021 Q1	$105K	Sell	2,220 -260	-10%	-$15.4K	0.01%	668
2020 Q4	$151K	Sell	2,480 -380	-13%	-$22.4K	0.02%	541
2020 Q3	$169K	Sell	2,860 -115	-4%	-$5.66K	0.02%	482
2020 Q2	$151K	Buy	2,975 +1,760	+145%	+$86.5K	0.02%	512
2020 Q1	$54K	Buy	1,215 +585	+93%	+$29.5K	0.01%	687
2019 Q4	$30K	Buy	+630	New	+$26.8K	﹤0.01%	833
2016 Q1	–	Sell	-9,102	Closed	-$295K	–	923
2015 Q4	$295K	Buy	9,102 +4,354	+92%	+$128K	0.03%	577
2015 Q3	$127K	Sell	4,748 -1,000	-17%	-$42.8K	0.01%	772
2015 Q2	$277K	Sell	5,748 -4,096	-42%	-$239K	0.02%	645
2015 Q1	$599K	Sell	9,844 -4,722	-32%	-$288K	0.05%	442
2014 Q4	$754K	Buy	14,566 +9,890	+212%	+$435K	0.06%	399
2014 Q3	$206K	Buy	+4,676	New	+$146K	0.02%	713

Other funds holding PTCT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

First Mercantile Trust's PTCT Position: Q3 2021 in Review

First Mercantile Trust increased its PTC Therapeutics (PTCT) stake by 18% in Q3 2021, buying an estimated $15K and bringing the position to 2,371 shares worth $88K. The position accounts for 0.01% of the portfolio, ranked #693.

First Mercantile Trust first reported a position in PTCT in Q3 2014 and has held it in 14 quarters since. The position peaked at $754K in Q4 2014. 182 funds tracked by Wall St. Rank hold PTCT as of Q3 2021.

First Mercantile Trust held 2,371 shares of PTC Therapeutics worth $88K as of Q3 2021.
First Mercantile Trust bought 366 PTC Therapeutics shares in Q3 2021, an estimated $15K.
PTC Therapeutics made up 0.01% of First Mercantile Trust's portfolio in Q3 2021, its #693 holding.
First Mercantile Trust first reported a position in PTC Therapeutics in Q3 2014 and has held it in 14 quarters since.
First Mercantile Trust's PTC Therapeutics position peaked at $754K in Q4 2014.
182 funds tracked by Wall St. Rank held PTC Therapeutics as of Q3 2021.

Based on First Mercantile Trust's 13F filing for Q3 2021, filed 24 Nov 2021.